The Role of Biomarker Testing in the Management of Metastatic Melanoma

Source: OncLive, November 2023

Expert panelists stress the importance of biomarker testing for BRAF mutations to guide treatment options when a patient is diagnosed with metastatic melanoma.
READ THE ORIGINAL FULL ARTICLE